Skip to main content
. 2019 Nov 1;10(6):1106–1121. doi: 10.1016/j.apsb.2019.10.011

Figure 4.

Figure 4

Anti-tumor effects in A549 cells. (A) Platinum–DNA adducts were examined using flow cytometry by CP9/19 antibody. (B) The quantification of Platinum–DNA adducts. (C) Viabilities of A549 cells treated with various drug formulations for 24 h. IC50 was calculated. (D) Hoechst 33258 nucleus staining. (E) Annexin V-APC/PI double staining cell apoptosis. Untreated cells were used as control. Data are expressed as mean ± SD (n = 3). *P < 0.05, **P < 0.01.